José Gazulla

12PUBLICATIONS
0CO-AUTHORS
Major global burdens of diseaseElectrical energy transmission, networks and systemsDevelopmental genetics (incl. sex determination)Exercise physiologyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 21, 2024
Potential Clinical Benefit of Very Long Chain Fatty Acid Supplementation in Spinocerebellar Ataxia Type 34.

José Gazulla, José Berciano

|Jul 17, 2023
Potential Benefit of Channel Activators in Loss-of-Function Primary Potassium Channelopathies Causing Heredoataxia.

José Gazulla, José Berciano

|May 08, 2023
Spinocerebellar ataxia type 15 caused by missense variants in the ITPR1 gene.

José Gazulla, Elena Bellosta-Diago, Silvia Izquierdo-Alvarez

|Apr 19, 2022
Two-year follow-up of docosahexaenoic acid supplementation in spinocerebellar ataxia type 38 (SCA38).

José Gazulla, Isabel Benavente, Elena García-González

|Oct 25, 2021
Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: Supplementary evidence for a continuum.

José Gazulla, Silvia Izquierdo-Alvarez, Emilio Ruiz-Fernández

|Aug 19, 2021
Gabapentin Relieves Vertigo of Periodic Vestibulocerebellar Ataxia: 3 Cases and Possible Mechanism.

José Gazulla

Pageof 2

Frequent Collaborators